Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Deferred Taxes (2024 - 2025)

Historic Deferred Taxes for Theravance Biopharma (TBPH) over the last 2 years, with Q3 2025 value amounting to $994000.0.

  • Theravance Biopharma's Deferred Taxes rose 100444.44% to $994000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.1 million, marking a year-over-year change of. This contributed to the annual value of -$7.6 million for FY2024, which is 33613.97% down from last year.
  • Theravance Biopharma's Deferred Taxes amounted to $994000.0 in Q3 2025, which was up 100444.44% from -$10.7 million recorded in Q2 2025.
  • Theravance Biopharma's Deferred Taxes' 5-year high stood at $994000.0 during Q3 2025, with a 5-year trough of -$10.7 million in Q2 2025.